© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Grace Halsey
Articles
Understanding Gaps in Patient Knowledge of Cervical Cancer Screening
May 08, 2025
An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences.
Roflumilast Foam 0.3% Update: Pivotal Phase 3 Trial Outcomes Published in JAMA Dermatology, Arcutis Announces
May 08, 2025
Publication of the phase 3 ARRECTOR trial findings precede an anticipated PDUFA date of May 22, 2025, for the investigational foam, now under FDA review.
Machine Learning Model Effectively Predicts Depression Risk in Adults with COPD
May 07, 2025
The model demonstrated 70.63% accuracy for predicting depression, a common comorbidity seen in COPD and one that increases risk for negative outcomes.
Investigational GPR119 Agonist Shows Dual Hepatoprotective and Glycemic Benefits in MASH Patients
May 07, 2025
EASL 2025. DA-1241 significantly reduced plasma ALT levels, improved systemic inflammatory and fibrosis biomarkers, according to drug developer MetaVia.
Cervical Cancer Screening: What Physicians Can Do To Convince Patients
May 07, 2025
An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences.
Study Finds 40% of Research Participants Decline to Learn Results of Alzheimer Disease Biomarker Testing
May 07, 2025
The new findings are contrary to previous research that found family history of AD increases desire for testing and support the "right not to know."
Foluso Fakorede, MD: Racial Disparities in PAD Amputation Rates
May 06, 2025
Rates of amputation in Black Americans with peripheral arterial disease are 3-times higher than that of their White counterparts. Dr Fakorede, discusses, here.
Fremanezumab Demonstrates Dual Benefits in Adults with Migraine and Depression
May 06, 2025
New data from UNITE study suggest fremanezumab was effective in alleviating migraine and comorbid MDD in patients with both conditions.
Stool-Based Testing for Colorectal Cancer Screening is On the Rise: Expert Perspective with Mark Fendrick, MD
May 06, 2025
The increase in stool-based CRC testing is a logical trend, Hendrick said in an interview, given the convenience plus the 2 million younger adults now eligible for screening.
Identifying HPV Types: Preventing Over Treatment and Under Treatment
May 06, 2025
An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences.